Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Curr Opin Pediatr. 2011 Aug;23(4):421-8. doi: 10.1097/MOP.0b013e32834726a4.
Overview of congenital hypothyroidism caused by thyroid hormone synthesis defects, the current understanding of their pathophysiology, and clinical implications of molecular diagnoses.
Genetic defects in all known thyroid-specific factors required for thyroid hormone synthesis have been described. These include defects in iodide trapping (NIS), in the facilitated iodide efflux across the apical membrane (PDS), the organification of iodide within the follicular lumen (thyroid peroxidase, DUOX2, DUOXA2), the substrate for thyroid hormone synthesis (thyroglobulin) and the ability to recover and retain intrathyroidal iodine (iodotyrosine deiodinase). Clinical and biochemical evaluation aids in selecting the most appropriate candidate gene(s). A definite molecular diagnosis of thyroid dyshormonogenesis allows genetic counseling and has prognostic value in differentiating transient from permanent congenital hypothyroidism and predicting the response of patients to iodine supplementation as adjunct or alternative treatment to L-T4 replacement.
Congenital hypothyroidism due to thyroid dyshormonogenesis is a heterogenic disorder that may be caused by mutations in any of the known steps in the thyroid hormone biosynthesis pathway. An exact molecular diagnosis allows genetic counseling and the identification of asymptomatic mutation carriers at risk of recurrent hypothyroidism, and provides a rationale for adjunct iodide supplementation.
甲状腺激素合成缺陷导致先天性甲状腺功能减退的概述,目前对其病理生理学的认识,以及分子诊断的临床意义。
已经描述了所有已知的甲状腺激素合成所必需的甲状腺特异性因子的遗传缺陷。这些缺陷包括碘捕获(NIS)、顶端膜促进碘外排(PDS)、滤泡腔内碘化的有机化(甲状腺过氧化物酶、DUOX2、DUOXA2)、甲状腺激素合成的底物(甲状腺球蛋白)以及恢复和保留甲状腺内碘的能力(碘酪氨酸脱碘酶)。临床和生化评估有助于选择最合适的候选基因。甲状腺激素生成障碍的明确分子诊断可进行遗传咨询,并具有预后价值,可区分暂时性和永久性先天性甲状腺功能减退,预测患者对碘补充作为 L-T4 替代治疗的辅助或替代治疗的反应。
甲状腺激素生成障碍导致的先天性甲状腺功能减退是一种异质性疾病,可能由甲状腺激素生物合成途径中任何已知步骤的突变引起。确切的分子诊断可进行遗传咨询,并识别出无症状的突变携带者,这些携带者有复发性甲状腺功能减退的风险,并为辅助碘补充提供了依据。